Conference Proceedings

Oral Abstract: ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts)

Carmelo Carlo-Stella, Cyrus Khan, Martin Hutchings, Fritz C Offner, Franck Morschhauser, Emmanuel Bachy, Michael Crump, Anna Sureda, Gloria Iacoboni, Corinne Haioun, David Perez-Callejo, Linda Lundberg, James Relf, Emma Clark, David Carlile, Emily Piccione, Anton Belousov, Kathryn Humphrey, Michael J Dickinson

Clinical Lymphoma Myeloma and Leukemia | Elsevier BV | Published : 2021